• Anti-ROR1 Antibody: Applied Research Workflows

  2026-09-16

  Anti-ROR1 Antibody (Zilovertamab) supports a connected workflow from recombinant ROR1 binding and cell-surface profiling to Wnt5a pathway perturbation. Its strongest differentiation is the ability to pair quantitative ELISA and FACS validation with carefully controlled functional and translational studies.

• Busulfan Workflows for Senescence and Germ Cell Depletion

  2026-09-16

  Busulfan provides a practical DNA-damage tool for dose-responsive senescence studies in WI38 fibroblasts and injury-based germ-cell depletion models. When paired with dual-recombinase lineage tracing, it helps distinguish genuine cell regeneration from persistence or loss of pre-existing ovarian germ cells.

• NNC-55–0396, Calcium Signaling, and GBM Autophagy

  2026-09-15

  The reference study shows that NNC-55–0396 kills glioblastoma cells through a dual autophagy disturbance: it stimulates autophagy through ER calcium mobilization and IRE1α/JNK1 stress signaling while simultaneously impairing late-stage lysosomal degradation. This mechanistic framework links calcium-dependent stress responses, cytoplasmic vacuolation, lysosomal alkalinization, and cell death, providing useful guidance for designing pathway-resolved glioblastoma experiments.

• CDK4/6 and BET Inhibition in Pancreatic Cancer

  2026-09-15

  Gu et al. show that combining CDK4/6 inhibition with BET inhibition suppresses pancreatic ductal adenocarcinoma growth while counteracting the pro-invasive EMT response associated with palbociclib alone. Their data connect GSK3β-mediated Wnt/β-catenin activation with TGF-β/Smad pathway crosstalk, providing a mechanistic rationale for dual-pathway treatment design.

• Anlotinib Hydrochloride: From Target to Readout

  2026-09-14

  Anlotinib hydrochloride links VEGFR2, PDGFRβ, and FGFR1 inhibition to measurable angiogenic phenotypes. This article presents a mechanism-to-readout framework for cancer research, helping researchers distinguish endothelial effects from direct tumor-cell cytostasis and improve translational interpretation.

• GCG, Nucleocapsid Condensates, and SARS-CoV-2 Replication

  2026-09-14

  The reference study identifies RNA-triggered liquid–liquid phase separation of the SARS-CoV-2 nucleocapsid protein as a functional process linked to viral replication. It further shows that the green-tea polyphenol GCG can disrupt N–RNA condensation and suppress viral replication, providing a mechanistic framework for studying antiviral compounds that target biomolecular condensates.

• Rotigotine Hydrochloride: Stability to Study Design

  2026-09-13

  Rotigotine hydrochloride is a dopamine D2/D3 receptor agonist with broad utility in Parkinson’s disease research and neurobiology. This guide connects receptor pharmacology with chiral purity, oxidation control, formulation choice, and assay design for more interpretable results.

• KN-62: From CaMKII Mechanism to Translation

  2026-09-12

  KN-62 offers a focused way to interrogate CaMKII within calcium-dependent biology. By connecting secretion, metabolism, cell-cycle phenotypes, and the Ca2+-autophagy findings reported in glioblastoma research, this article outlines a translational workflow that separates causal kinase effects from broader calcium perturbation.

• WY-14643 as a PPARα Benchmark for PFAS Studies

  2026-09-11

  WY-14643, also called Pirinixic Acid, provides a pharmacological benchmark for interpreting PPARα-dependent lipid disruption. This article connects its assay use with integrated zebrafish lipidomics and transcriptomics in PFHxS research, emphasizing controls, formulation, and mechanistic limits.

• Native protein gel electrophoresis: K4142 workflow

  2026-09-11

  Build a reproducible native-PAGE workflow for acidic proteins while preserving charge, conformation, complexes, and enzyme activity. The K4142 kit is especially useful when SDS-PAGE would erase the structural or functional signal needed for purification, identification, or mechanistic follow-up.

• Angiotensin Peptides and SARS-CoV-2 Spike Binding

  2026-09-10

  A 2025 study found that naturally occurring angiotensin peptides can increase SARS-CoV-2 spike-protein binding to the AXL receptor, with shorter fragments and selected tyrosine modifications showing especially strong effects. The work connects renin-angiotensin system peptide processing with viral receptor biology while emphasizing that binding results require validation in cellular and physiological models.

• WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis

  2026-09-10

  The reference study identifies the WNT5a/GSK3/β-catenin axis as a regulatory circuit that restrains adipogenic differentiation of skeletal muscle fibro/adipogenic progenitors. By combining pharmacological perturbation, mass cytometry, transcriptomic integration, network modeling, and mouse injury models, it links pathway disruption with fatty degeneration and altered muscle regeneration.

• TaqI Restriction Endonuclease Protocol

  2026-09-09

  TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific digestion of plasmid DNA, PCR products, and genomic DNA for cloning and molecular biology workflows. It is intended for research use, not diagnostic or medical applications, and should be applied with the supplier’s specified reaction conditions.

• Hexetidine: From MIC to Oral Biofilm Evidence

  2026-09-09

  Hexetidine (NSC-17764) is a broad-spectrum oral antimicrobial whose value depends on matching concentration, exposure, and endpoint to the research question. This evidence-calibrated guide connects strain-specific MIC data, biofilm inhibition assays, and clinical plaque and gingivitis findings without treating them as interchangeable.

• JC-1 and the DRP1 Death Axis in ATC

  2026-09-08

  A mechanism-led guide to using JC-1 in anaplastic thyroid carcinoma research, connecting mitochondrial membrane potential with the JAK1/2–STAT3–DRP1 pathway, apoptosis, pyroptosis, and translational assay design.

8058 records 1/538 page Next 12345 下5页 Last page